Tenax Therapeutics (TENX) Prepaid Assets (2011 - 2026)
Tenax Therapeutics (TENX) reported Prepaid Assets of $4.3 million for Q1 2026, up 723.66% on a YoY basis from $524000.0 in Q1 2025, and up 438.15% sequentially from $802000.0 in Q4 2025.
Tenax Therapeutics (TENX) Prepaid Assets (2011 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 15 years of Prepaid Assets data on file, last reported at $4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 723.66% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 723.66% YoY), and the FY2025 full-year result was $802000.0, down 54.71% from the prior year.
- Prepaid Assets climbed to $4.3 million in Q1 2026, from $802000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.3 million in Q1 2026 to a low of $33875.0 in Q3 2024.
- A 5-year average of $977304.8 and a median of $524000.0 in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 92.87% in 2024 and soared 10057.93% in 2025, its largest moves.
- Tracing TENX's Prepaid Assets over 5 years: stood at $345856.0 in 2022, then soared by 374.19% to $1.6 million in 2023, then gained by 7.99% to $1.8 million in 2024, then slumped by 54.71% to $802000.0 in 2025, then surged by 438.15% to $4.3 million in 2026.
- Business Quant data shows TENX's Prepaid Assets at $4.3 million in Q1 2026, $802000.0 in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.32 Mn |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 395,000.00 |
| Mar 31, 2025 | 524,000.00 |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 33,875.00 |
| Jun 30, 2024 | 50,250.00 |
| Mar 31, 2024 | 66,625.00 |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 474,866.00 |
| Jun 30, 2023 | 282,583.00 |
| Mar 31, 2023 | 304,583.00 |
| Dec 31, 2022 | 345,856.00 |
| Sep 30, 2022 | 707,194.00 |
| Jun 30, 2022 | 872,363.00 |
| Mar 31, 2022 | 586,987.00 |
| Sep 30, 2021 | 229,152.00 |
| Jun 30, 2021 | 349,862.00 |
| Mar 31, 2021 | 485,935.00 |